How would you manage a provoked blood clot for a patient who had been placed on low dose DOAC for history of unprovoked blood clot?

To clarify the scenario: the patient had an unprovoked VTE for which they are currently on low dose DOAC and now have experienced recurrence in association with a well-defined (as outlined in ASH guidelines Ortel et al., PMID 33007077) provoking event. A number of additional variables would weigh in...